{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:26:23Z","timestamp":1755797183478,"version":"3.44.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,18]]},"DOI":"10.7759\/cureus.90408","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T16:46:28Z","timestamp":1755535588000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of Cognitive Decline in Individuals With Diabetes in the United States"],"prefix":"10.7759","author":[{"given":"Siya","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansi","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlok","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Fastring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.12865\/CHSJ.50.02.02","article-title":"Cognitive decline in ageing and disease: risk factors, genetics and treatments","volume":"50","author":"Colita E","year":"2024","unstructured":"Colita E, Mateescu VO, Olaru DG, Popa-Wagner A. Cognitive decline in ageing and disease: risk factors, genetics and treatments. Curr Health Sci J. 2024, 50:170-80. 10.12865\/CHSJ.50.02.02","journal-title":"Curr Health Sci J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2020.10.027","article-title":"Probiotics treatment improves cognitive impairment in patients and animals: a systematic review and meta-analysis","volume":"120","author":"Lv T","year":"2021","unstructured":"Lv T, Ye M, Luo F, et al.. Probiotics treatment improves cognitive impairment in patients and animals: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2021, 120:159-72. 10.1016\/j.neubiorev.2020.10.027","journal-title":"Neurosci Biobehav Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15313","article-title":"Incremental burden on health-related quality of life, health service utilization and direct medical expenditures associated with cognitive impairment among non-institutionalized people with diabetes aged 65\u2009years and older","volume":"26","author":"Guan D","year":"2024","unstructured":"Guan D, Lewis MO, Li P, et al.. Incremental burden on health-related quality of life, health service utilization and direct medical expenditures associated with cognitive impairment among non-institutionalized people with diabetes aged 65\u2009years and older. Diabetes Obes Metab. 2024, 26:275-82. 10.1111\/dom.15313","journal-title":"Diabetes Obes Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v14.i2.92","article-title":"Diabetes and cognitive function: an evidence-based current perspective","volume":"14","author":"Sebastian MJ","year":"2023","unstructured":"Sebastian MJ, Khan SK, Pappachan JM, Jeeyavudeen MS. Diabetes and cognitive function: an evidence-based current perspective. World J Diabetes. 2023, 14:92-109. 10.4239\/wjd.v14.i2.92","journal-title":"World J Diabetes"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22193","article-title":"Cognitive impairment in type 2 diabetes mellitus","volume":"14","author":"Malik A","year":"2022","unstructured":"Malik A, Ahmed M, Mansoor S, Ambreen S, Usman B, Shehryar M. Cognitive impairment in type 2 diabetes mellitus. Cureus. 2022, 14:e22193. 10.7759\/cureus.22193","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28305","article-title":"Factors associated with mild cognitive impairment in patients with type 2 diabetes: a cohort study","volume":"14","author":"Rhmari Tlem\u00e7ani FZ","year":"2022","unstructured":"Rhmari Tlem\u00e7ani FZ, Elamari S, Motaib I, Laidi S, Alidrissi N, Ahid S, Chadli A. Factors associated with mild cognitive impairment in patients with type 2 diabetes: a cohort study. Cureus. 2022, 14:e28305. 10.7759\/cureus.28305","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73138","article-title":"Type 2 diabetes mellitus accelerates brain aging and cognitive decline: complementary findings from UK Biobank and meta-analyses","volume":"11","author":"Antal B","year":"2022","unstructured":"Antal B, McMahon LP, Sultan SF, et al.. Type 2 diabetes mellitus accelerates brain aging and cognitive decline: complementary findings from UK Biobank and meta-analyses. Elife. 2022, 11:0. 10.7554\/eLife.73138","journal-title":"Elife"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116144","article-title":"Diagnostic, prognostic, and mechanistic biomarkers of diabetes mellitus-associated cognitive decline","volume":"23","author":"Ehtewish H","year":"2022","unstructured":"Ehtewish H, Arredouani A, El-Agnaf O. Diagnostic, prognostic, and mechanistic biomarkers of diabetes mellitus-associated cognitive decline. Int J Mol Sci. 2022, 23:6114. 10.3390\/ijms23116144","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v14.i6.795","article-title":"Diabetes and cognitive decline: challenges and future direction","volume":"14","author":"Ab-Hamid N","year":"2023","unstructured":"Ab-Hamid N, Omar N, Ismail CA, Long I. Diabetes and cognitive decline: challenges and future direction. World J Diabetes. 2023, 14:795-807. 10.4239\/wjd.v14.i6.795","journal-title":"World J Diabetes"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neures.2025.104932","article-title":"Formyl peptide receptor 2 antagonist WRW4 ameliorates diabetes-induced cognitive decline in mice","volume":"218","author":"Uno H","year":"2025","unstructured":"Uno H, Itokazu T, Yamashita T. Formyl peptide receptor 2 antagonist WRW4 ameliorates diabetes-induced cognitive decline in mice. Neurosci Res. 2025, 218:104932. 10.1016\/j.neures.2025.104932","journal-title":"Neurosci Res"},{"unstructured":"Centers for Disease Control and Prevention. behavioral risk factor surveillance system (BRFSS) frequently asked questions (FAQs). (2018). Accessed: November 3, 2024: https:\/\/www.cdc.gov\/brfss\/about\/brfss_faq.htm.","key":"ref11"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4541-7","article-title":"HbA(1c), diabetes and cognitive decline: the English longitudinal study of ageing","volume":"61","author":"Zheng F","year":"2018","unstructured":"Zheng F, Yan L, Yang Z, Zhong B, Xie W. HbA(1c), diabetes and cognitive decline: the English longitudinal study of ageing. Diabetologia. 2018, 61:839-48. 10.1007\/s00125-017-4541-7","journal-title":"Diabetologia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glx255","article-title":"Cerebral structure and cognitive performance in African Americans and European Americans with type 2 diabetes","volume":"73","author":"Hsu FC","year":"2018","unstructured":"Hsu FC, Sink KM, Hugenschmidt CE, et al.. Cerebral structure and cognitive performance in African Americans and European Americans with type 2 diabetes. J Gerontol A Biol Sci Med Sci. 2018, 73:407-14. 10.1093\/gerona\/glx255","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-021-02740-7","article-title":"Explanatory role of sociodemographic, clinical, behavioral, and social factors on cognitive decline in older adults with diabetes","volume":"22","author":"O'Toole SM","year":"2022","unstructured":"O'Toole SM, Walker RJ, Garacci E, Dawson AZ, Campbell JA, Egede LE. Explanatory role of sociodemographic, clinical, behavioral, and social factors on cognitive decline in older adults with diabetes. BMC Geriatr. 2022, 22:39. 10.1186\/s12877-021-02740-7","journal-title":"BMC Geriatr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/gps.6010","article-title":"Cognitive status and its risk factors in patients with hypertension and diabetes in a low-income rural area of China: a cross-sectional study","volume":"38","author":"Guo Y","year":"2023","unstructured":"Guo Y, Liang R, Ren J, et al.. Cognitive status and its risk factors in patients with hypertension and diabetes in a low-income rural area of China: a cross-sectional study. Int J Geriatr Psychiatry. 2023, 38:e6010. 10.1002\/gps.6010","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-11068-1","article-title":"Racial and ethnic disparities in subjective cognitive decline: a closer look, United States, 2015-2018","volume":"21","author":"Gupta S","year":"2021","unstructured":"Gupta S. Racial and ethnic disparities in subjective cognitive decline: a closer look, United States, 2015-2018. BMC Public Health. 2021, 21:1173. 10.1186\/s12889-021-11068-1","journal-title":"BMC Public Health"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16771-6","article-title":"Social determinants and lifestyle factors for brain health: implications for risk reduction of cognitive decline and dementia","volume":"12","author":"R\u00f6hr S","year":"2022","unstructured":"R\u00f6hr S, Pabst A, Baber R, et al.. Social determinants and lifestyle factors for brain health: implications for risk reduction of cognitive decline and dementia. Sci Rep. 2022, 12:12965. 10.1038\/s41598-022-16771-6","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.16321","article-title":"Aging, diabetes, obesity, and cognitive decline: a population-based study","volume":"68","author":"Ganguli M","year":"2020","unstructured":"Ganguli M, Beer JC, Zmuda JM, Ryan CM, Sullivan KJ, Chang CH, Rao RH. Aging, diabetes, obesity, and cognitive decline: a population-based study. J Am Geriatr Soc. 2020, 68:991-8. 10.1111\/jgs.16321","journal-title":"J Am Geriatr Soc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0120","article-title":"The association of late-life diabetes status and hyperglycemia with incident mild cognitive impairment and dementia: The ARIC study","volume":"42","author":"Rawlings AM","year":"2019","unstructured":"Rawlings AM, Sharrett AR, Albert MS, et al.. The association of late-life diabetes status and hyperglycemia with incident mild cognitive impairment and dementia: The ARIC study. Diabetes Care. 2019, 42:1248-54. 10.2337\/dc19-0120","journal-title":"Diabetes Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-04977-9","article-title":"Cognitive dysfunction in diabetes: how to implement emerging guidelines","volume":"63","author":"Biessels GJ","year":"2020","unstructured":"Biessels GJ, Whitmer RA. Cognitive dysfunction in diabetes: how to implement emerging guidelines. Diabetologia. 2020, 63:3-9. 10.1007\/s00125-019-04977-9","journal-title":"Diabetologia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/370919-prevalence-of-cognitive-decline-in-individuals-with-diabetes-in-the-united-states","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T16:46:29Z","timestamp":1755535589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/370919-prevalence-of-cognitive-decline-in-individuals-with-diabetes-in-the-united-states"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.90408","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,8,18]]}}}